Steroid intraocular implants having an extended sustained release for a period of greater than two months

Details for Australian Patent Application No. 2010200935 (hide)

Owner Allergan, Inc.

Inventors Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest

Agent Davies Collison Cave

Pub. Number AU-B-2010200935

Parent 2005240092

Filing date 11 March 2010

Wipo publication date 1 April 2010

Acceptance publication date 29 September 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 31/573 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

Event Publications

25 March 2010 Complete Application Filed

1 April 2010 Application Open to Public Inspection

  Published as AU-B-2010200935

29 September 2011 Application Accepted

  Published as AU-B-2010200935

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200936-Reusable wrapping material for a cylindrical cotton module

2010200934-Adapter for a self-drilling, chemically anchorable fastening element